Anjali S. Advani

Research interests

Publications

• Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults

  New England Journal of Medicine · 2024 · https://doi.org/10.1056/nejmoa2312948

• Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies

  Clinical Cancer Research · 2021 · https://doi.org/10.1158/1078-0432.ccr-20-3706

• Acute Lymphoblastic Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

  Journal of the National Comprehensive Cancer Network · 2021 · https://doi.org/10.6004/jnccn.2021.0042

• Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia

  Blood · 2020 · https://doi.org/10.1182/blood.2020007732

• Inotuzumab ozogamicin versus standard of care in relapsed or refractory acute lymphoblastic leukemia: Final report and long‐term survival follow‐up from the randomized, phase 3 INO‐VATE study

  Cancer · 2019 · https://doi.org/10.1002/cncr.32116

• A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403

  Blood · 2019 · https://doi.org/10.1182/blood-2018-10-881961

• Hepatic adverse event profile of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukaemia: results from the open-label, randomised, phase 3 INO-VATE study

  The Lancet Haematology · 2017 · https://doi.org/10.1016/s2352-3026(17)30103-5

• Risk of Hematologic Malignancies After Radioiodine Treatment of Well-Differentiated Thyroid Cancer

  Journal of Clinical Oncology · 2017 · https://doi.org/10.1200/jco.2017.75.0232

• A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia

  Blood · 2017 · https://doi.org/10.1182/blood-2017-06-789800

• Incorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes

  Leukemia · 2016 · https://doi.org/10.1038/leu.2016.138

• Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia

  New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1509277

• International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemia

  Haematologica · 2016 · https://doi.org/10.3324/haematol.2016.144311

• Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms

  Leukemia · 2013 · https://doi.org/10.1038/leu.2013.269

• SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes

  Blood · 2012 · https://doi.org/10.1182/blood-2012-05-430876

• Inotuzumab ozogamicin, an anti-CD22–calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study

  The Lancet Oncology · 2012 · https://doi.org/10.1016/s1470-2045(11)70386-2

• CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia

  Blood · 2011 · https://doi.org/10.1182/blood-2010-06-292433

• Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panel

  Leukemia & lymphoma/Leukemia and lymphoma · 2011 · https://doi.org/10.3109/10428194.2011.596963

• Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies

  Blood · 2011 · https://doi.org/10.1182/blood-2010-07-295857

• Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse

  Blood · 2011 · https://doi.org/10.1182/blood-2010-08-301796

• Safety, Pharmacokinetics, and Preliminary Clinical Activity of Inotuzumab Ozogamicin, a Novel Immunoconjugate for the Treatment of B-Cell Non-Hodgkin's Lymphoma: Results of a Phase I Study

  Journal of Clinical Oncology · 2010 · https://doi.org/10.1200/jco.2009.25.1900

• Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients

  Blood · 2008 · https://doi.org/10.1182/blood-2008-05-157065

• Barriers to the participation of African‐American patients with cancer in clinical trials

  Cancer · 2003 · https://doi.org/10.1002/cncr.11213

Current projects

No projects listed.